{"id":"https://openalex.org/W2904445846","doi":"https://doi.org/10.1021/acsmedchemlett.8b00414","title":"Maximizing ER-\u03b1 Degradation Maximizes Activity in a Tamoxifen-Resistant Breast Cancer Model: Identification of GDC-0927","display_name":"Maximizing ER-\u03b1 Degradation Maximizes Activity in a Tamoxifen-Resistant Breast Cancer Model: Identification of GDC-0927","publication_year":2018,"publication_date":"2018-12-06","ids":{"openalex":"https://openalex.org/W2904445846","doi":"https://doi.org/10.1021/acsmedchemlett.8b00414","mag":"2904445846","pmid":"https://pubmed.ncbi.nlm.nih.gov/30655946","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6331158"},"language":"en","primary_location":{"id":"doi:10.1021/acsmedchemlett.8b00414","doi":"https://doi.org/10.1021/acsmedchemlett.8b00414","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acsmedchemlett.8b00414","pdf_url":null,"source":{"id":"https://openalex.org/S191852912","display_name":"ACS Medicinal Chemistry Letters","issn_l":"1948-5875","issn":["1948-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6331158","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Mehmet Kahraman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mehmet Kahraman","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059378712","display_name":"Steven P. Govek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven P. Govek","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021286275","display_name":"Johnny Y. Nagasawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johnny Y. Nagasawa","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065142951","display_name":"Andiliy G. Lai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andiliy Lai","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072118690","display_name":"C\u00e9line Bonnefous","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Celine Bonnefous","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007455917","display_name":"Karensa L. Douglas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karensa Douglas","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006915014","display_name":"John Sensintaffar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Sensintaffar","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014109314","display_name":"Nhin Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nhin Liu","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072729167","display_name":"KyoungJin Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"KyoungJin Lee","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050565684","display_name":"Anna M. Aparicio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Aparicio","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108468666","display_name":"Josh Kaufman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Josh Kaufman","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001637232","display_name":"Jing Qian","orcid":"https://orcid.org/0000-0001-6120-5147","observed_orcids":["https://orcid.org/0000-0001-6120-5147"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing Qian","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100518237","display_name":"Gang Shao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gang Shao","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006279759","display_name":"Rene Y. Prudente","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rene Prudente","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037379407","display_name":"James D. Joseph","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James D. Joseph","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012291117","display_name":"Beatrice D. Darimont","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Beatrice Darimont","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087085239","display_name":"Daniel Brigham","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Brigham","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014567706","display_name":"Richard A. Heyman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Heyman","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077906047","display_name":"Peter J. Rix","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter J. Rix","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079488873","display_name":"Jeffrey H. Hager","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey H. Hager","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Biology, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102820332","display_name":"Nicholas D. Smith","orcid":"https://orcid.org/0000-0001-5791-8849","observed_orcids":["https://orcid.org/0000-0001-5791-8849"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Nicholas D. Smith","raw_affiliation_strings":["Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States"],"raw_orcid":"https://orcid.org/0000-0001-5791-8849","affiliations":[{"raw_affiliation_string":"Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]},{"raw_affiliation_string":"Department of Chemistry, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5102820332"],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":5.9666,"has_fulltext":false,"cited_by_count":78,"citation_normalized_percentile":{"value":0.97321149,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"10","issue":"1","first_page":"50","last_page":"55"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.9613999724388123,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.9613999724388123,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.02500000037252903,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/selective-estrogen-receptor-degrader","display_name":"selective estrogen receptor degrader","score":0.9710000157356262},{"id":"https://openalex.org/keywords/tamoxifen-resistance","display_name":"tamoxifen resistance","score":0.972000002861023},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9110000133514404},{"id":"https://openalex.org/keywords/side-chain-substitution","display_name":"side-chain substitution","score":0.7139999866485596},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.7829999923706055},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.7070000171661377}],"concepts":[{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.8087589144706726},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.7503589391708374},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7440690994262695},{"id":"https://openalex.org/C2777944059","wikidata":"https://www.wikidata.org/wiki/Q903917","display_name":"Selective estrogen receptor modulator","level":5,"score":0.5028366446495056},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.48301371932029724},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.48287728428840637},{"id":"https://openalex.org/C172313692","wikidata":"https://www.wikidata.org/wiki/Q14902310","display_name":"Estrogen receptor alpha","level":5,"score":0.45086580514907837},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41874730587005615},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.41457685828208923},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.410230815410614},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35182568430900574},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3453575074672699}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1021/acsmedchemlett.8b00414","doi":"https://doi.org/10.1021/acsmedchemlett.8b00414","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acsmedchemlett.8b00414","pdf_url":null,"source":{"id":"https://openalex.org/S191852912","display_name":"ACS Medicinal Chemistry Letters","issn_l":"1948-5875","issn":["1948-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5903630","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6331158","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6331158","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6331158","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Med Chem Lett","raw_type":"Text"},{"id":"pmid:30655946","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30655946","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:5903630","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6331158","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W2013809140","https://openalex.org/W2013956549","https://openalex.org/W2016908879","https://openalex.org/W2036673057","https://openalex.org/W2037460676","https://openalex.org/W2070440733","https://openalex.org/W2089595068","https://openalex.org/W2101833345","https://openalex.org/W2137234779","https://openalex.org/W2258559299","https://openalex.org/W2323968754","https://openalex.org/W2580935506","https://openalex.org/W2886595387","https://openalex.org/W4254152438"],"related_works":["https://openalex.org/W2886595387","https://openalex.org/W2323968754","https://openalex.org/W2060004930","https://openalex.org/W2012767871","https://openalex.org/W2969166825","https://openalex.org/W2138154153","https://openalex.org/W2993770527","https://openalex.org/W6977827027","https://openalex.org/W2886595719","https://openalex.org/W4362677105"],"abstract_inverted_index":{"The":[0],"further":[1],"optimization":[2],"of":[3,7,10,39,64,99],"ER-\u03b1":[4,66,87],"degradation":[5,53,75,88],"efficacy":[6,54,76,89],"a":[8,45,97],"series":[9],"ER":[11],"modulators":[12],"by":[13],"refining":[14],"side-chain":[15],"substitution":[16],"led":[17],"to":[18,31,91],"efficacious":[19],"selective":[20],"estrogen":[21,115],"receptor":[22],"degraders":[23],"(SERDs).":[24],"A":[25],"fluoromethyl":[26],"azetidine":[27],"group":[28],"was":[29,106],"found":[30],"be":[32],"preferred":[33],"and":[34],"resulted":[35],"in":[36,96,108,111],"the":[37],"identification":[38],"bis-phenol":[40],"chromene":[41],"17ha":[42,51,104],".":[43],"In":[44],"tamoxifen-resistant":[46,100],"breast":[47,101,117],"cancer":[48],"xenograft":[49],"model,":[50],"(ER-\u03b1":[52,74],"=":[55,77],"97%)":[56],"demonstrated":[57],"tumor":[58],"regression,":[59],"together":[60],"with":[61,93,113],"robust":[62,94],"reduction":[63],"intratumoral":[65],"levels.":[67],"However,":[68],"despite":[69],"superior":[70],"oral":[71],"exposure,":[72],"5a":[73],"91%)":[78],"had":[79],"inferior":[80],"activity.":[81],"This":[82],"result":[83],"suggests":[84],"that":[85],"optimizing":[86],"leads":[90],"compounds":[92],"effects":[95],"model":[98],"cancer.":[102,118],"Compound":[103],"(GDC-0927)":[105],"evaluated":[107],"clinical":[109],"trials":[110],"women":[112],"metastatic":[114],"receptor-positive":[116]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":14}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2018-12-22T00:00:00"}